Financials EP Biocomposites Limited

Equities

543595

INE0D2I01014

Construction Supplies & Fixtures

Market Closed - Bombay S.E. 06:00:54 2024-06-12 am EDT 5-day change 1st Jan Change
161 INR -2.69% Intraday chart for EP Biocomposites Limited -2.39% -14.54%

Valuation

Fiscal Period: March 2023
Capitalization 1 338.8
Enterprise Value (EV) 1 329.7
P/E ratio 51.1 x
Yield -
Capitalization / Revenue 4.75 x
EV / Revenue 4.62 x
EV / EBITDA 30,766,283 x
EV / FCF 37,423,784 x
FCF Yield 0%
Price to Book 4.03 x
Nbr of stocks (in thousands) 1,682
Reference price 2 201.5
Announcement Date 8/18/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023
Net sales 1 34.1 29.48 80.6 71.31
EBITDA - 4.601 13.83 10.72
EBIT 1 2.592 4.598 13.17 9.721
Operating Margin 7.6% 15.6% 16.34% 13.63%
Earnings before Tax (EBT) 1 2.592 4.642 11.66 8.14
Net income 1 1.896 3.58 8.094 5.761
Net margin 5.56% 12.14% 10.04% 8.08%
EPS - 9.547 9.480 3.940
Free Cash Flow - -0.1752 -48.59 8.81
FCF margin - -0.59% -60.28% 12.36%
FCF Conversion (EBITDA) - - - 82.21%
FCF Conversion (Net income) - - - 152.93%
Dividend per Share - - - -
Announcement Date 2/2/22 2/2/22 8/18/23 8/18/23
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023
Net Debt 1 - - 39.6 -
Net Cash position 1 1.13 1.48 - 9.1
Leverage (Debt/EBITDA) - - 2.86 x -
Free Cash Flow - -0.18 -48.6 8.81
ROE (net income / shareholders' equity) - 172% 67.9% 11.1%
ROA (Net income/ Total Assets) - 30.6% 15.5% 5.79%
Assets 1 - 11.68 52.13 99.57
Book Value Per Share - 10.30 17.10 50.00
Cash Flow per Share - 3.940 1.330 13.00
Capex - 0.03 4.74 0.22
Capex / Sales - 0.09% 5.88% 0.31%
Announcement Date 2/2/22 2/2/22 8/18/23 8/18/23
1INR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 543595 Stock
  4. Financials EP Biocomposites Limited